Premium
Animal-focused pharmaceuticals company Ashish Life Science Pvt. Ltd is in talks to raise a fresh round of equity funding after a hiatus of more than six years, two people aware of the development told VCCircle. The planned round may also provide an exit route to the Mumbai-based company’s early institutional backers, the ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
